WPI 2264 Pill - yellow capsule/oblong, 18mm
Pill with imprint WPI 2264 is Yellow, Capsule/Oblong and has been identified as Acitretin 17.5 mg. It is supplied by Actavis Pharma, Inc.
Acitretin is used in the treatment of Psoriasis and belongs to the drug class antipsoriatics. Not for use in pregnancy. Acitretin 17.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WPI 2264
Acitretin
- Imprint
- WPI 2264
- Strength
- 17.5 mg
- Color
- Yellow
- Size
- 18.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Antipsoriatics
- Pregnancy Category
- X - Not for use in pregnancy
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Actavis Pharma, Inc.
- National Drug Code (NDC)
- 00591-2264 (Discontinued)
- Inactive Ingredients
-
maltodextrin,
sodium ascorbate,
microcrystalline cellulose,
gelatin,
sodium lauryl sulfate,
titanium dioxide,
ferric oxide yellow,
shellac,
ferrosoferric oxide,
propylene glycol
Note: Inactive ingredients may vary.
More about acitretin
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (35)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: antipsoriatics
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
